Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis
- 1 May 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 86 (5) , 554-558
- https://doi.org/10.1016/0002-9343(89)90384-7
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Detection of specific sequences among DNA fragments separated by gel electrophoresisPublished by Elsevier ,2006
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- Essential thrombocythemia. Clinical characteristics and course of 61 casesCancer, 1988
- Anagrelide: A New Drug for Treating ThrombocytosisNew England Journal of Medicine, 1988
- Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disordersCancer Immunology, Immunotherapy, 1987
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986
- Uncontrolled thrombocytosis in chronic myeloproliferative disordersBritish Journal of Haematology, 1982
- Increased Incidence of Acute Leukemia in Polycythemia Vera Associated with Chlorambucil TherapyNew England Journal of Medicine, 1981
- Primary or hemorrhagic thrombocythemiaArchives of internal medicine (1960), 1968
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945